Organon (OGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Cruz announces that investors with losses related to Organon & Co. ("Organon" or the "Company") (NYSE: OGN) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN ...

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Organon & Co. ("Organon" or the "Company") (NYSE: OGN) of a class action securities lawsuit. CLASS ...

INCHEON, Korea & JERSEY CITY, N.J., May 27, 2025--Organon and Samsung Bioepis' HADLIMA granted FDA interchangeability designation approval for all high- and-low concentration presentations.

LOS ANGELES, June 13, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Organon & Co. ("Organon" or "the Company") (NYSE: OGN) for violations of the ...

More Bonds of Organon & Co./ Organon Foreign Debt Co-Issuer B.V. About the Organon & Co./ Organon Foreign Debt Co-Issuer B.V.-Bond (XS2332250708) The Organon & Co./ Organon Foreign Debt Co-Issuer ...

Story April 9 - Organon: The women’s health drugmaker is initiating New Jersey layoffs that will hit 93 staffers. The company is undergoing a revamp and has been reducing its headcount in ...